In the JAK/STAT pathway, we currently have some new treatments, topically, to treat vitiligo that have been shown to be very effective, especially on the face, which is, of course, one of the most ...

Incyte is preparing to take an oral JAK inhibitor into phase 3 trials for the skin depigmentation disease vitiligo, after reporting mid-stage data showing efficacy in patients with facial and full ...

Analysts said that the warning, which follows an FDA review of the safety of the JAK inhibitor class ... a treatment for skin pigmentation disease vitiligo. Its approval for atopic dermatitis ...

Oral JAK inhibitors such as ritlecitinib ... “The question of safety is important because vitiligo is a visible but nonsevere condition, and we do not want to expose patients to unnecessary ...

On the other hand, King said the fact that vitiligo is an autoimmune disease that responds to JAK inhibitors, as do other autoimmune diseases, may also be a factor in the decision algorithm ...

Vitiligo is associated with increased cardiovascular disease risk, affecting organ function and metabolic syndrome. A large-scale US study found 54 cardiovascular diseases with increased risk in ...

Model Winnie Harlow felt isolated when first diagnosed with vitiligo but now says it's one of her "greatest gifts" A controversial new treatment for a condition called vitiligo that can restore ...